{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:36:06Z","timestamp":1787020566696,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"WBE Liver Fibrosis Foundation","award":["CFHPC2022025"],"award-info":[{"award-number":["CFHPC2022025"]}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2024AFD090"],"award-info":[{"award-number":["2024AFD090"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Inflamm"],"DOI":"10.1186\/s12950-026-00492-y","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T04:53:39Z","timestamp":1772513619000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Resolvin D1 alleviates liver inflammation and fibrosis through SIRT1-mediated NF-\u03baB and TGF-\u03b21\/Smads pathways"],"prefix":"10.1186","volume":"23","author":[{"given":"Jiahuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwen","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"492_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","volume":"65","author":"M Parola","year":"2019","unstructured":"Parola M, Pinzani M. Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med. 2019;65:37\u201355. https:\/\/doi.org\/10.1016\/j.mam.2018.09.002.","journal-title":"Mol Aspects Med"},{"issue":"1","key":"492_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151\u201371. https:\/\/doi.org\/10.1016\/j.jhep.2018.09.014.","journal-title":"J Hepatol"},{"issue":"2","key":"492_CR3","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. 2023;79(2):516\u201337. https:\/\/doi.org\/10.1016\/j.jhep.2023.03.017.","journal-title":"J Hepatol"},{"issue":"10","key":"492_CR4","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","volume":"20","author":"L Hammerich","year":"2023","unstructured":"Hammerich L, Tacke F. Hepatic inflammatory responses in liver fibrosis. Nat Reviews Gastroenterol Hepatol. 2023;20(10):633\u201346. https:\/\/doi.org\/10.1038\/s41575-023-00807-x.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"issue":"3","key":"492_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Reviews Gastroenterol Hepatol. 2021;18(3):151\u201366. https:\/\/doi.org\/10.1038\/s41575-020-00372-7.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"issue":"2","key":"492_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.14348\/molcells.2016.2318","volume":"39","author":"BL Tang","year":"2016","unstructured":"Tang BL. Sirt1 and the mitochondria. Mol Cells. 2016;39(2):87\u201395. https:\/\/doi.org\/10.14348\/molcells.2016.2318.","journal-title":"Mol Cells"},{"issue":"2","key":"492_CR7","doi-asserted-by":"publisher","first-page":"484","DOI":"10.7150\/ijbs.78654","volume":"19","author":"C Lu","year":"2023","unstructured":"Lu C, Zhao H, Liu Y, Yang Z, Yao H, Liu T, et al. Novel role of the sirt1 in endocrine and metabolic diseases. Int J Biol Sci. 2023;19(2):484\u2013501. https:\/\/doi.org\/10.7150\/ijbs.78654.","journal-title":"Int J Biol Sci"},{"issue":"4","key":"492_CR8","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2021.11.026","volume":"76","author":"K Kadono","year":"2022","unstructured":"Kadono K, Kageyama S, Nakamura K, Hirao H, Ito T, Kojima H, et al. Myeloid ikaros-sirt1 signaling axis regulates hepatic inflammation and pyroptosis in ischemia-stressed mouse and human liver. J Hepatol. 2022;76(4):896\u2013909. https:\/\/doi.org\/10.1016\/j.jhep.2021.11.026.","journal-title":"J Hepatol"},{"issue":"6","key":"492_CR9","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.jhep.2017.08.010","volume":"67","author":"K Nakamura","year":"2017","unstructured":"Nakamura K, Zhang M, Kageyama S, Ke B, Fujii T, Sosa RA, et al. Macrophage heme oxygenase-1-sirt1-p53 axis regulates sterile inflammation in liver ischemia-reperfusion injury. J Hepatol. 2017;67(6):1232\u201342. https:\/\/doi.org\/10.1016\/j.jhep.2017.08.010.","journal-title":"J Hepatol"},{"issue":"Pt B","key":"492_CR10","doi-asserted-by":"publisher","first-page":"111002","DOI":"10.1016\/j.intimp.2023.111002","volume":"124","author":"H Lu","year":"2023","unstructured":"Lu H, Zhang R, Zhang S, Li Y, Liu Y, Xiong Y, et al. Hsc-derived exosomal mir-199a-5p promotes hsc activation and hepatocyte emt via targeting sirt1 in hepatic fibrosis. Int Immunopharmacol. 2023;124(Pt B):111002. https:\/\/doi.org\/10.1016\/j.intimp.2023.111002.","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"492_CR11","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.jhep.2016.11.004","volume":"66","author":"T Ramirez","year":"2017","unstructured":"Ramirez T, Li Y, Yin S, Xu M, Feng D, Zhou Z, et al. Aging aggravates alcoholic liver injury and fibrosis in mice by downregulating sirtuin 1 expression. J Hepatol. 2017;66(3):601\u20139. https:\/\/doi.org\/10.1016\/j.jhep.2016.11.004.","journal-title":"J Hepatol"},{"issue":"2","key":"492_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.taap.2015.09.028","volume":"289","author":"Y Wu","year":"2015","unstructured":"Wu Y, Liu X, Zhou Q, Huang C, Meng X, Xu F, et al. Silent information regulator 1 (sirt1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion. Toxicol Appl Pharmcol. 2015;289(2):163\u201376. https:\/\/doi.org\/10.1016\/j.taap.2015.09.028.","journal-title":"Toxicol Appl Pharmcol"},{"issue":"12","key":"492_CR13","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1016\/j.bbadis.2017.09.008","volume":"1863","author":"M Li","year":"2017","unstructured":"Li M, Hong W, Hao C, Li L, Xu H, Li P, et al. Hepatic stellate cell-specific deletion of sirt1 exacerbates liver fibrosis in mice. Biochim Et Biophys Acta-Molecular Basis Disease. 2017;1863(12):3202\u201311. https:\/\/doi.org\/10.1016\/j.bbadis.2017.09.008.","journal-title":"Biochim Et Biophys Acta-Molecular Basis Disease"},{"issue":"1","key":"492_CR14","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1096\/fj.201700612R","volume":"32","author":"M Li","year":"2018","unstructured":"Li M, Hong W, Hao C, Li L, Wu D, Shen A, et al. Sirt1 antagonizes liver fibrosis by blocking hepatic stellate cell activation in mice. Faseb J. 2018;32(1):500\u201311. https:\/\/doi.org\/10.1096\/fj.201700612R.","journal-title":"Faseb J"},{"issue":"5","key":"492_CR15","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/bcpt.13446","volume":"127","author":"L Yang","year":"2020","unstructured":"Yang L, Ao Q, Zhong Q, Li W, Li W. Sirt1\/igfbprp1\/tgf \u03b21 axis involved in cucurbitacin b ameliorating concanavalin a-induced mice liver fibrosis. Basic Clin Pharmacol Toxicol. 2020;127(5):371\u20139. https:\/\/doi.org\/10.1111\/bcpt.13446.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"492_CR16","doi-asserted-by":"publisher","first-page":"110979","DOI":"10.1016\/j.cbi.2024.110979","volume":"394","author":"Y Xia","year":"2024","unstructured":"Xia Y, Luo Q, Gao Q, Huang C, Chen P, Zou Y, et al. Sirt1 activation ameliorates rhesus monkey liver fibrosis by inhibiting the tgf-\u03b2\/smad signaling pathway. Chemico-Biol Interact. 2024;394:110979. https:\/\/doi.org\/10.1016\/j.cbi.2024.110979.","journal-title":"Chemico-Biol Interact"},{"key":"492_CR17","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.toxlet.2016.09.014","volume":"262","author":"Y Yang","year":"2016","unstructured":"Yang Y, Bai T, Yao Y, Zhang D, Wu Y, Lian L, et al. Upregulation of sirt1-ampk by thymoquinone in hepatic stellate cells ameliorates liver injury. Toxicol Lett. 2016;262:80\u201391. https:\/\/doi.org\/10.1016\/j.toxlet.2016.09.014.","journal-title":"Toxicol Lett"},{"issue":"10","key":"492_CR18","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1111\/1440-1681.13546","volume":"48","author":"AM Shamseldeen","year":"2021","unstructured":"Shamseldeen AM, Al-Ani B, Ebrahim HA, Rashed L, Badr AM, Attia A, et al. Resveratrol suppresses cholestasis-induced liver injury and fibrosis in rats associated with the inhibition of tgf\u03b21-smad3-mir21 axis and profibrogenic and hepatic injury biomarkers. Clin Exp Pharmacol Physiol. 2021;48(10):1402\u201311. https:\/\/doi.org\/10.1111\/1440-1681.13546.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"9","key":"492_CR19","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.it.2022.07.004","volume":"43","author":"D Capece","year":"2022","unstructured":"Capece D, Verzella D, Flati I, Arboretto P, Cornice J, Franzoso G. Nf-\u03bab: blending metabolism, immunity, and inflammation. Trends Immunol. 2022;43(9):757\u201375. https:\/\/doi.org\/10.1016\/j.it.2022.07.004.","journal-title":"Trends Immunol"},{"issue":"2","key":"492_CR20","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1007\/s10753-021-01586-w","volume":"45","author":"Z Ma","year":"2022","unstructured":"Ma Z, Sheng L, Li J, Qian J, Wu G, Wang Z, et al. Resveratrol alleviates hepatic fibrosis in associated with decreased endoplasmic reticulum stress-mediated apoptosis and inflammation. Inflammation. 2022;45(2):812\u201323. https:\/\/doi.org\/10.1007\/s10753-021-01586-w.","journal-title":"Inflammation"},{"issue":"7","key":"492_CR21","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s00011-024-01890-9","volume":"73","author":"X Zhao","year":"2024","unstructured":"Zhao X, Li M, Lu Y, Wang M, Xiao J, Xie Q, et al. Sirt1 inhibits macrophage polarization and inflammation in gouty arthritis by inhibiting the mapk\/nf-\u03bab\/ap-1 pathway and activating the nrf2\/ho-1 pathway. Inflamm Res. 2024;73(7):1173\u201384. https:\/\/doi.org\/10.1007\/s00011-024-01890-9.","journal-title":"Inflamm Res"},{"key":"492_CR22","doi-asserted-by":"publisher","first-page":"101165","DOI":"10.1016\/j.plipres.2022.101165","volume":"86","author":"SC Dyall","year":"2022","unstructured":"Dyall SC, Balas L, Bazan NG, Brenna JT, Chiang N, Da Costa Souza F, et al. Polyunsaturated fatty acids and fatty acid-derived lipid mediators: recent advances in the understanding of their biosynthesis, structures, and functions. Prog Lipid Res. 2022;86:101165. https:\/\/doi.org\/10.1016\/j.plipres.2022.101165.","journal-title":"Prog Lipid Res"},{"issue":"5","key":"492_CR23","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1007\/s10753-018-0819-2","volume":"41","author":"Y Zhuo","year":"2018","unstructured":"Zhuo Y, Zhang S, Li C, Yang L, Gao H, Wang X. Resolvin d1 promotes sirt1 expression to counteract the activation of stat3 and nf-\u03bab in mice with septic-associated lung injury. Inflammation. 2018;41(5):1762\u201371. https:\/\/doi.org\/10.1007\/s10753-018-0819-2.","journal-title":"Inflammation"},{"issue":"6","key":"492_CR24","doi-asserted-by":"publisher","first-page":"L1013","DOI":"10.1152\/ajplung.00415.2018","volume":"316","author":"Y Yang","year":"2019","unstructured":"Yang Y, Hu L, Xia H, Chen L, Cui S, Wang Y, et al. Resolvin d1 attenuates mechanical stretch-induced pulmonary fibrosis via epithelial-mesenchymal transition. Am J Physiology-Lung Cell Mol Physiol. 2019;316(6):L1013\u201324. https:\/\/doi.org\/10.1152\/ajplung.00415.2018.","journal-title":"Am J Physiology-Lung Cell Mol Physiol"},{"issue":"14","key":"492_CR25","doi-asserted-by":"publisher","first-page":"e2308978","DOI":"10.1002\/advs.202308978","volume":"11","author":"Y Kang","year":"2024","unstructured":"Kang Y, Kim D, Lee S, Kim H, Kim T, Cho JA, et al. Innate immune training initiates efferocytosis to protect against lung injury. Adv Sci. 2024;11(14):e2308978. https:\/\/doi.org\/10.1002\/advs.202308978.","journal-title":"Adv Sci"},{"issue":"1","key":"492_CR26","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/gut.2004.042127","volume":"54","author":"L Xu","year":"2005","unstructured":"Xu L, Hui AY, Albanis E, Arthur MJ, O\u2019Byrne SM, Blaner WS, et al. Human hepatic stellate cell lines, lx-1 and lx-2: new tools for analysis of hepatic fibrosis. Gut. 2005;54(1):142\u201351. https:\/\/doi.org\/10.1136\/gut.2004.042127.","journal-title":"Gut"},{"issue":"2","key":"492_CR27","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1096\/fj.13-235614","volume":"28","author":"B Rius","year":"2014","unstructured":"Rius B, Titos E, Mor\u00e1n-Salvador E, L\u00f3pez-Vicario C, Garc\u00eda-Alonso V, Gonz\u00e1lez-P\u00e9riz A, et al. Resolvin d1 primes the resolution process initiated by calorie restriction in obesity-induced steatohepatitis. Faseb J. 2014;28(2):836\u201348. https:\/\/doi.org\/10.1096\/fj.13-235614.","journal-title":"Faseb J"},{"key":"492_CR28","doi-asserted-by":"publisher","first-page":"106961","DOI":"10.1016\/j.intimp.2020.106961","volume":"88","author":"J Li","year":"2020","unstructured":"Li J, Deng X, Bai T, Wang S, Jiang Q, Xu K. Resolvin d1 mitigates non-alcoholic steatohepatitis by suppressing the tlr4-myd88-mediated nf-\u03bab and mapk pathways and activating the nrf2 pathway in mice. Int Immunopharmacol. 2020;88:106961. https:\/\/doi.org\/10.1016\/j.intimp.2020.106961.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"492_CR29","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.7150\/ijbs.80122","volume":"19","author":"J Ding","year":"2023","unstructured":"Ding J, Xu M, Du W, Fang Z, Xu H, Liu J, et al. Myeloid-specific blockade of notch signaling ameliorates nonalcoholic fatty liver disease in mice. Int J Biol Sci. 2023;19(6):1941\u201354. https:\/\/doi.org\/10.7150\/ijbs.80122.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"492_CR30","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s10787-023-01382-y","volume":"32","author":"DK Mostafa","year":"2024","unstructured":"Mostafa DK, Eissa MM, Ghareeb DA, Abdulmalek S, Hewedy WA. Resveratrol protects against schistosoma mansoni-induced liver fibrosis by targeting the sirt-1\/nf-\u03bab axis. Inflammopharmacology. 2024;32(1):763\u201375. https:\/\/doi.org\/10.1007\/s10787-023-01382-y.","journal-title":"Inflammopharmacology"},{"issue":"11","key":"492_CR31","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.3390\/cells8111419","volume":"8","author":"B Dewidar","year":"2019","unstructured":"Dewidar B, Meyer C, Dooley S, Meindl-Beinker AN. Tgf-\u03b2 in hepatic stellate cell activation and liver fibrogenesis-updated 2019. Cells. 2019;8(11):1419. https:\/\/doi.org\/10.3390\/cells8111419.","journal-title":"Cells"},{"key":"492_CR32","doi-asserted-by":"publisher","first-page":"651645","DOI":"10.3389\/fphys.2021.651645","volume":"12","author":"Z Li","year":"2021","unstructured":"Li Z, Liu Z, Lu H, Dai W, Chen J, He L. Rvd1 attenuated susceptibility to ischemic aki in diabetes by downregulating nuclear factor-\u03bab signal and inhibiting apoptosis. Front Physiol. 2021;12:651645. https:\/\/doi.org\/10.3389\/fphys.2021.651645.","journal-title":"Front Physiol"},{"issue":"5","key":"492_CR33","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.3390\/molecules28052417","volume":"28","author":"CPB Melo","year":"2023","unstructured":"Melo CPB, Saito P, Martinez RM, Staurengo-Ferrari L, Pinto IC, Rodrigues CCA, et al. Aspirin-triggered resolvin d1 (AT-RvD1) protects mouse skin against uvb-induced inflammation and oxidative stress. Molecules. 2023;28(5):2471. https:\/\/doi.org\/10.3390\/molecules28052417.","journal-title":"Molecules"},{"issue":"8","key":"492_CR34","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1016\/j.transproceed.2008.07.040","volume":"40","author":"JH Jang","year":"2008","unstructured":"Jang JH, Kang KJ, Kim YH, Kang YN, Lee IS. Reevaluation of experimental model of hepatic fibrosis induced by hepatotoxic drugs: an easy, applicable, and reproducible model. Transpl Proc. 2008;40(8):2700\u20133. https:\/\/doi.org\/10.1016\/j.transproceed.2008.07.040.","journal-title":"Transpl Proc"},{"key":"492_CR35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1471-230X-10-79","volume":"10","author":"T Fujii","year":"2010","unstructured":"Fujii T, Fuchs BC, Yamada S, Lauwers GY, Kulu Y, Goodwin JM, et al. Mouse model of carbon tetrachloride induced liver fibrosis: histopathological changes and expression of cd133 and epidermal growth factor. BMC Gastroenterol. 2010;10:79. https:\/\/doi.org\/10.1186\/1471-230X-10-79.","journal-title":"BMC Gastroenterol"},{"issue":"9","key":"492_CR36","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.2174\/0115665240257603230919103539","volume":"24","author":"MM Fareed","year":"2024","unstructured":"Fareed MM, Khalid H, Khalid S, Shityakov S. Deciphering molecular mechanisms of carbon tetrachloride- induced hepatotoxicity: a brief systematic review. Curr Mol Med. 2024;24(9):1124\u201334. https:\/\/doi.org\/10.2174\/0115665240257603230919103539.","journal-title":"Curr Mol Med"},{"issue":"1","key":"492_CR37","doi-asserted-by":"publisher","first-page":"H240","DOI":"10.1111\/1750-3841.13157","volume":"81","author":"D Zhang","year":"2016","unstructured":"Zhang D, Sun P, Jin Q, Li X, Zhang Y, Zhang Y, et al. Resveratrol regulates activated hepatic stellate cells by modulating nf-\u03bab and the pi3k\/akt signaling pathway. J Food Sci. 2016;81(1):H240\u20135. https:\/\/doi.org\/10.1111\/1750-3841.13157.","journal-title":"J Food Sci"},{"issue":"3","key":"492_CR38","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/wsbm.1331","volume":"8","author":"S Mitchell","year":"2016","unstructured":"Mitchell S, Vargas J, Hoffmann A. Signaling via the nf\u03bab system. Wiley Interdisciplinary Reviews-Systems Biology Med. 2016;8(3):227\u201341. https:\/\/doi.org\/10.1002\/wsbm.1331.","journal-title":"Wiley Interdisciplinary Reviews-Systems Biology Med"},{"issue":"6","key":"492_CR39","doi-asserted-by":"publisher","first-page":"559","DOI":"10.4196\/kjpp.2024.28.6.559","volume":"28","author":"W Hao","year":"2024","unstructured":"Hao W, Yu T, Li W, Wang G, Hu H, Zhou P. Hemin attenuates bleomycin-induced lung fibrosis in mice by regulating the tgf-\u03b21\/mapk and ampk\/sirt1\/pgc-1\u03b1\/ho-1\/nf-\u03bab pathways. Korean J Physiol Pharmacol. 2024;28(6):559\u201368. https:\/\/doi.org\/10.4196\/kjpp.2024.28.6.559.","journal-title":"Korean J Physiol Pharmacol"},{"key":"492_CR40","doi-asserted-by":"publisher","first-page":"155655","DOI":"10.1016\/j.phymed.2024.155655","volume":"130","author":"T Jiang","year":"2024","unstructured":"Jiang T, Sun L, Wang Y, Zhang F, Guo J, Sun L, et al. Podophyllotoxin via sirt1\/ppar\/nf-\u03bab axis induced cardiac injury in rats based on the toxicological evidence chain (tec) concept. Phytomedicine. 2024;130:155655. https:\/\/doi.org\/10.1016\/j.phymed.2024.155655.","journal-title":"Phytomedicine"},{"issue":"8","key":"492_CR41","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1164\/rccm.200708-1269OC","volume":"177","author":"S Rajendrasozhan","year":"2008","unstructured":"Rajendrasozhan S, Yang S, Kinnula VL, Rahman I. Sirt1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;177(8):861\u201370. https:\/\/doi.org\/10.1164\/rccm.200708-1269OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"492_CR42","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1369\/0022155415627681","volume":"64","author":"F Xu","year":"2016","unstructured":"Xu F, Liu C, Zhou D, Zhang L. Tgf-\u03b2\/smad pathway and its regulation in hepatic fibrosis. J Histochem Cytochemistry. 2016;64(3):157\u201367. https:\/\/doi.org\/10.1369\/0022155415627681.","journal-title":"J Histochem Cytochemistry"}],"container-title":["Journal of Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12950-026-00492-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12950-026-00492-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12950-026-00492-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T11:47:26Z","timestamp":1775648846000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12950-026-00492-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["492"],"URL":"https:\/\/doi.org\/10.1186\/s12950-026-00492-y","relation":{},"ISSN":["1476-9255"],"issn-type":[{"value":"1476-9255","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"22 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}